These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15064459)

  • 1. Affinity capillary electrophoresis analyses of protein-protein interactions in target-directed drug discovery.
    Pierceall WE; Zhang L; Hughes DE
    Methods Mol Biol; 2004; 261():187-98. PubMed ID: 15064459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophoretic methods for studying protein-protein interactions.
    Vergnon AL; Chu YH
    Methods; 1999 Oct; 19(2):270-7. PubMed ID: 10527731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoaffinity capillary electrophoresis: determination of binding constant and stoichiometry for antibody-antigen interaction.
    Tseng WL; Chang HT; Hsu SM; Chen RJ; Lin S
    Electrophoresis; 2002 Mar; 23(6):836-46. PubMed ID: 11920868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial-filling affinity capillary electrophoresis techniques to probe the binding of glycopeptide antibiotics to D-Ala-D-Ala terminus peptides.
    Zavaleta J; Chinchilla DB; Kaddis CF; Martinez K; Brown A; Gomez A; Pao A; Ramirez A; Nilapwar S; Ladbury JE; Gomez FA
    J Capill Electrophor Microchip Technol; 2006; 9(5-6):101-17. PubMed ID: 17094294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioanalytical interaction studies executed by preincubation affinity capillary electrophoresis.
    Ostergaard J; Heegaard NH
    Electrophoresis; 2006 Jul; 27(13):2590-608. PubMed ID: 16732622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for transient biological interactions as applied to albumin ligands: a new concept for drug discovery.
    Ohlson S; Shoravi S; Fex T; Isaksson R
    Anal Biochem; 2006 Dec; 359(1):120-3. PubMed ID: 17052679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-protein interaction studies based on molecular aptamers by affinity capillary electrophoresis.
    Huang CC; Cao Z; Chang HT; Tan W
    Anal Chem; 2004 Dec; 76(23):6973-81. PubMed ID: 15571349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein interaction mapping for target validation: the need for an integrated combinatory process involving complementary approaches.
    Strosberg AD
    Curr Opin Mol Ther; 2002 Dec; 4(6):594-600. PubMed ID: 12596362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic capillary electrophoresis (KCE): a conceptual platform for kinetic homogeneous affinity methods.
    Petrov A; Okhonin V; Berezovski M; Krylov SN
    J Am Chem Soc; 2005 Dec; 127(48):17104-10. PubMed ID: 16316258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-interaction mapping in search of effective drug targets.
    Chaudhuri A; Chant J
    Bioessays; 2005 Sep; 27(9):958-69. PubMed ID: 16108076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering novel binding proteins from nonimmunoglobulin domains.
    Binz HK; Amstutz P; Plückthun A
    Nat Biotechnol; 2005 Oct; 23(10):1257-68. PubMed ID: 16211069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical approaches for discovering protein-protein interactions.
    Miernyk JA; Thelen JJ
    Plant J; 2008 Feb; 53(4):597-609. PubMed ID: 18269571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput identification of transient extracellular protein interactions.
    Wright GJ; Martin S; Bushell KM; Söllner C
    Biochem Soc Trans; 2010 Aug; 38(4):919-22. PubMed ID: 20658977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of smart aptamers by methods of kinetic capillary electrophoresis.
    Drabovich AP; Berezovski M; Okhonin V; Krylov SN
    Anal Chem; 2006 May; 78(9):3171-8. PubMed ID: 16643010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
    Watt PM
    Nat Biotechnol; 2006 Feb; 24(2):177-83. PubMed ID: 16465163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
    Buchwald P
    IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a green fluorescent fusion protein to study protein-protein interactions by electrophoretic methods.
    Kiessig S; Reissmann J; Rascher C; Küllertz G; Fischer A; Thunecke F
    Electrophoresis; 2001 Apr; 22(7):1428-35. PubMed ID: 11379967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly.
    Erlanson DA; Hansen SK
    Curr Opin Chem Biol; 2004 Aug; 8(4):399-406. PubMed ID: 15288250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capillary electrophoresis frontal analysis: principles and applications for the study of drug-plasma protein binding.
    Østergaard J; Heegaard NH
    Electrophoresis; 2003 Sep; 24(17):2903-13. PubMed ID: 12973793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.